Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - High frequency of false-positive results and their analysis

Journal of Medical Microbiology

Volumn 59, Issue 9, 2010, Pages 1016-1022

  Racil, Zdenek ^a   Kocmanova, Iva ^a   Lengerova, Martina ^a   Weinbergerova, Barbora ^a   Buresova, Lucie ^b   Toskova, Martina ^a   Winterova, Jana ^a   Timilsina, Shira ^b   Rodriguez, Isa ^b   Mayer, Jiri ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BLOOD SAMPLING; CANCER CHEMOTHERAPY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FUNGAL COLONIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS;

ANTINEOPLASTIC AGENTS; BETA-GLUCANS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOASSAY; IMMUNOCOMPROMISED HOST; MALE; MYCOSES; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 77956499049     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.019299-0     Document Type: Article

References (34)

1. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E. & other authors (2002). Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34, 7-14. (Pubitemid 33152659)
2. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O. & other authors (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46, 1813-1821.
3. Desmet, S., Van Wijngaerden, E., Maertens, J., Verhaegen, J., Verbeken, E., De Munter, P., Meersseman, W., Van Meensel, B., Van Eldere, J. & other authors (2009). Serum (1-3)-β-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 47, 3871-3874.
4. Digby, J., Kalbfleisch, J., Glenn, A., Larsen, A., Browder, W. & Williams, D. (2003). Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10, 882-885. (Pubitemid 37129504)
5. Ellis, M., Al-Ramadi, B., Finkelman, M., Hedstrom, U., Kristensen, J., Ali-Zadeh, H. & Klingspor, L. (2008). Assessment of the clinical utility of serial β-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 57, 287-295. (Pubitemid 351358531)
6. Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S. & Bearden, D. T. (2006). Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43, 25-31. (Pubitemid 43939072)
7. Hachem, R. Y., Kontoyiannis, D. P., Chemaly, R. F., Jiang, Y., Reitzel, R. & Raad, I. (2009). Utility of galactomannan enzyme immunoassay and (1,3) β-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47, 129-133.
8. Kedzierska, A., Kochan, P., Pietrzyk, A. & Kedzierska, J. (2007). Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-β-D-glucan antigens. Eur J Clin Microbiol Infect Dis 26, 755-766. (Pubitemid 47573385)
9. Koo, S., Bryar, J. M., Page, J. H., Baden, L. R. & Marty, F. M. (2009). Diagnostic performance of the (1→3)-β-D-glucan assay for invasive fungal disease. Clin Infect Dis 49, 1650-1659.
10. Maertens, J., Van Eldere, J., Verhaegen, J., Verbeken, E., Verschakelen, J. & Boogaerts, M. (2002). Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 186, 1297-1306. (Pubitemid 35193008)
11. Maertens, J., Theunissen, K., Verbeken, E., Lagrou, K., Verhaegen, J., Boogaerts, M. & Eldere, J. V. (2004). Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 126, 852-860. (Pubitemid 39273827)
12. Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M. & other authors (2005). Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 41, 1242-1250. (Pubitemid 41534660)
13. Maertens, J. A., Klont, R., Masson, C., Theunissen, K., Meersseman, W., Lagrou, K., Heinen, C., Crepin, B., Van Eldere, J. & other authors (2007). Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 44, 1329-1336. (Pubitemid 46729195)
14. Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. (2002). Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34, 909-917. (Pubitemid 34229758)
15. Marr, K. A., Balajee, S. A., McLaughlin, L., Tabouret, M., Bentsen, C. & Walsh, T. J. (2004). Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190, 641-649. (Pubitemid 38982107)
16. Marty, F. M., Lowry, C. M., Lempitski, S. J., Kubiak, D. W., Finkelman, M. A. & Baden, L. R. (2006). Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 50, 3450-3453.
17. Mattiuzzi, G., Kantarjian, H., Odabasi, Z., Alvarado, G., Paetznick, V., Rodríguez, J., Chen, E. & Ostrosky-Zeichner, L. (2007). Diagnostic performance of serum galactomannan (GM) and β-glucan (BG) in a cohort of 395 patients (pts) with acute leukemia on antifungal prophylaxis. In Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, abstract M-578. Washington, DC: American Society for Microbiology.
18. Mengoli, C., Cruciani, M., Barnes, R. A., Loeffler, J. & Donnelly, J. P. (2009). Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9, 89-96.
19. Mennink-Kersten, M. A., Ruegebrink, D. & Verweij, P. E. (2007). Reactivity of bacteria with the 1,3-β-glucan assay. In Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, abstract M-568. Washington, DC: American Society for Microbiology.
20. Nagasawa, K., Yano, T., Kitabayashi, G., Morimoto, H., Yamada, Y., Ohata, A., Usami, M. & Horiuchi, T. (2003). Experimental proof of contamination of blood components by (1→3)-β-D-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Organs 6, 49-54. (Pubitemid 36554087)
21. Obayashi, T., Negishi, K., Suzuki, T. & Funata, N. (2008). Reappraisal of the serum (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin Infect Dis 46, 1864-1870.
22. Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H. & other authors (2004). β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39, 199-205. (Pubitemid 38971490)
23. Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R. & other authors (2005). Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41, 654-659. (Pubitemid 41170353)
24. Pagano, L., Caira, M., Candoni, A., Offidani, M., Fianchi, L., Martino, B., Pastore, D., Picardi, M., Bonini, A. & other authors (2006). The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91, 1068-1075. (Pubitemid 44208634)
25. Pazos, C., Ponton, J. & Del Palacio, A. (2005). Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43, 299-305. (Pubitemid 40096315)
26. Persat, F., Topenot, R., Piens, M. A., Thiebaut, A., Dannaoui, E. & Picot, S. (2002). Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis. Mycoses 45, 455-460. (Pubitemid 35471999)
27. Persat, F., Ranque, S., Derouin, F., Michel-Nguyen, A., Picot, S. & Sulahian, A. (2008). Contribution of the (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 46, 1009-1013. (Pubitemid 351379994)
28. Pickering, J. W., Sant, H. W., Bowles, C. A., Roberts, W. L. & Woods, G. L. (2005). Evaluation of a (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43, 5957-5962.
29. Sendid, B., Poirot, J. L., Tabouret, M., Bonnin, A., Caillot, D., Camus, D. & Poulain, D. (2002). Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 51, 433-442. (Pubitemid 34450601)
30. Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J. & other authors (2008). 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46, 878-885. (Pubitemid 351417190)
31. Usami, M., Ohata, A., Horiuchi, T., Nagasawa, K., Wakabayashi, T. & Tanaka, S. (2002). Positive (1→3)-β-D-glucan in blood components and release of (1→3)-β-D-glucan from depth-type membrane filters for blood processing. Transfusion 42, 1189-1195.
32. von Eiff, M., Roos, N., Schulten, R., Hesse, M., Zuhlsdorf, M. & van de Loo, J. (1995). Pulmonary aspergillosis: early diagnosis improves survival. Respiration 62, 341-347.
33. Watanabe, T., Yasuoka, A., Tanuma, J., Yazaki, H., Honda, H., Tsukada, K., Honda, M., Gatanaga, H., Teruya, K. & other authors (2009). Serum (1→3) β-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 49, 1128-1131.
34. WHO (1979). WHO Handbook for Reporting Results of Cancer Treatment, 1st edn, pp. 15-22. Geneva, Switzerland: World Health Organization.